Clinical trial
A Clinical Trial to Evaluate Kerecis Oral™ Compared to Autogenous Free Gingival Graft (AFGG) Tissue to Augment Gingival Soft Tissue and Wound Healing
NCT03664401 is registered in ClinicalTrials.gov with Kerecis Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Clinical Trial to Evaluate Kerecis Oral™ Compared to Autogenous Free Gingival Graft (AFGG) Tissue to Augment Gingival Soft Tissue and Wound Healing
- Lead sponsor
- Kerecis Ltd.
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- September 1, 2016
- Completion date
- December 1, 2017
- Enrollment
- 6 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
mucogingival deformity - insufficient keratinized tissue